- Home
- OLLI vs BPMC Comparison
OLLI vs BPMC Comparison
Compare OLLI & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLLI
- BPMC
- Stock Information
- Founded
- OLLI 1982
- BPMC 2008
- Country
- OLLI United States
- BPMC United States
- Employees
- OLLI N/A
- BPMC N/A
- Industry
- OLLI Department/Specialty Retail Stores
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- OLLI Consumer Discretionary
- BPMC Health Care
- Exchange
- OLLI Nasdaq
- BPMC Nasdaq
- Market Cap
- OLLI 7.0B
- BPMC 7.0B
- IPO Year
- OLLI 2015
- BPMC 2015
- Fundamental
- Price
- OLLI $96.78
- BPMC $92.25
- Analyst Decision
- OLLI Strong Buy
- BPMC Buy
- Analyst Count
- OLLI 14
- BPMC 19
- Target Price
- OLLI $118.07
- BPMC $123.61
- AVG Volume (30 Days)
- OLLI 743.0K
- BPMC 1.1M
- Earning Date
- OLLI 03-19-2025
- BPMC 02-13-2025
- Dividend Yield
- OLLI N/A
- BPMC N/A
- EPS Growth
- OLLI 32.18
- BPMC N/A
- EPS
- OLLI 3.36
- BPMC N/A
- Revenue
- OLLI $2,253,570,000.00
- BPMC $508,824,000.00
- Revenue This Year
- OLLI $10.57
- BPMC $44.29
- Revenue Next Year
- OLLI $12.47
- BPMC $32.49
- P/E Ratio
- OLLI $28.78
- BPMC N/A
- Revenue Growth
- OLLI 12.48
- BPMC 104.04
- 52 Week Low
- OLLI $68.05
- BPMC $80.68
- 52 Week High
- OLLI $120.03
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- OLLI 34.51
- BPMC 34.05
- Support Level
- OLLI $102.05
- BPMC $90.84
- Resistance Level
- OLLI $109.62
- BPMC $96.78
- Average True Range (ATR)
- OLLI 3.55
- BPMC 4.34
- MACD
- OLLI -0.82
- BPMC -2.26
- Stochastic Oscillator
- OLLI 11.44
- BPMC 5.64
About OLLI Ollie's Bargain Outlet Holdings Inc.
Ollie's Bargain Outlet Holdings Inc is a retailer of brand-name merchandise at drastically reduced prices. It offers customers a selection of brand-name products, including housewares, food, books and stationery, bed and bath, floor coverings, toys, and hardware. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun, and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns. These attributes have driven rapid growth and consistent store performance for the company.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.